Press Releases

Newsroom
In the News
Press Releases
Resources for Journalists

Press Releases

Share
Share
and/or
510 News Releases found
(left to right) Jeffrey Vacirca, MD, FACP, Lisa M. DeAngelis, MD, Oscar B. Lahoud, MD, Selwyn M. Vickers, MD, FACS
New Practice of Memorial Sloan Kettering Cancer Center Physicians Opens in Flatbush, Brooklyn Improving Access to Exceptional Cancer Care

Leadership and staff from Memorial Sloan Kettering Cancer Center (MSK) joined leaders from New York Cancer & Blood Specialists (NYCBS) and Memorial Medical Care, PC (MMC), a practice of MSK physicians, to celebrate the recent opening of a new cancer care practice in the Flatbush section of Brooklyn.
Memorial Sloan Kettering Cancer Center Issues Statement on Fiscal Year 2022 Financial Results

Memorial Sloan Kettering Cancer Center (MSK) issued the following statement regarding its fiscal year 2022 financial results today.
Selwyn M. Vickers, MD, FACS, and Andrea Schietinger, PhD
MSK Experts To Receive Prestigious Awards at the American Association for Cancer Research (AACR) 2023 Annual Meeting

Memorial Sloan Kettering Cancer Center (MSK) is pleased to announce that Selwyn M. Vickers, MD, FACS, President and Chief Executive Officer of MSK, and Andrea Schietinger, PhD, Associate Member of the Immunology Program at the Sloan Kettering Institute will be honored at the 2023 American Association for Cancer Research (AACR) Annual Meeting for their significant contributions to cancer research and care.
Corning and Memorial Sloan Kettering Cancer Center Announce Health Equity Fellowship to Explore Disparities in Cancer Outcomes

Fellowship recipient Dr. Francisco Sanchez-Vega will research factors that lead to negative colorectal cancer outcomes in Black communities.
Memorial Sloan Kettering Cancer Center Experts to Present Noteworthy Research at the American Association for Cancer Research (AACR) 2023 Annual Meeting
Memorial Sloan Kettering Cancer Center Experts to Present Noteworthy Research at the American Association for Cancer Research (AACR) 2023 Annual Meeting

Physicians and scientists from Memorial Sloan Kettering Cancer Center (MSK) will join oncology experts and members of the global cancer research community to present the latest advances in cancer during the American Association for Cancer Research (AACR) Annual Meeting on April 14-19 in Orlando, Florida.
Luis F. Parada, PhD; Dana Pe’er, PhD; and Michel Sadelain, MD, PhD
Three Memorial Sloan Kettering Cancer Center (MSK) Scientific Leaders Elected as Fellows of the American Association for Cancer Research (AACR) Academy

Memorial Sloan Kettering Cancer Center (MSK) is pleased to announce three faculty are among the 23 international scientific leaders elected today to the prestigious Fellows of the American Association for Cancer Research (AACR) Academy class of 2023. All three are members of the Sloan Kettering Institute, a hub for basic science and translational research within MSK.
MSK Awards & Appointments January 2023
MSK Awards & Appointments February & March 2023

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.
LaKisha Mack Named Inaugural Chief Administrative Officer at Memorial Sloan Kettering Cancer Center
LaKisha Mack Named Inaugural Chief Administrative Officer at Memorial Sloan Kettering Cancer Center

In her role at MSK, Mack will direct the evolution and improvement of all business processes.
J. Ted Gerstle, MD, Chief of the Pediatric Surgery Service at MSK
Memorial Sloan Kettering Cancer Center is Named the First Ever Level I Specialty Children’s Surgery Center in Oncology by the American College of Surgeons

Memorial Sloan Kettering Cancer Center (MSK) has been recognized by the American College of Surgeons (ACS) for its commitment to providing optimal surgical care for children and adolescents.
Cycle for Survival
Cycle for Survival Kicks Off 2023 Events Nationwide with New Performance Apparel Sponsor Vuori

Along with founding partner Equinox, Cycle for Survival begins its signature team stationary-cycling events this week in New York City. 100% of funds raised go directly to rare cancer research at Memorial Sloan Kettering Cancer Center (MSK).